You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

List of Excipients in API relugolix

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing relugolix

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Sumitomo Pharma America Inc	ORGOVYX	relugolix	72974-120	CARNAUBA WAX	2036-02-25
Sumitomo Pharma America Inc	ORGOVYX	relugolix	72974-120	FERRIC OXIDE RED	2036-02-25
Sumitomo Pharma America Inc	ORGOVYX	relugolix	72974-120	HYDROXYPROPYL CELLULOSE	2036-02-25
Sumitomo Pharma America Inc	ORGOVYX	relugolix	72974-120	HYPROMELLOSE 2910	2036-02-25
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for relugolix

Excipient focus: CARNAUBA WAX

relugolix drug variants containing CARNAUBA WAX

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix	72974-120
>Company	>Ingredient	>NDC

relugolix drug variants not containing CARNAUBA WAX

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE RED

relugolix drug variants containing FERRIC OXIDE RED

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix	72974-120
>Company	>Ingredient	>NDC

relugolix drug variants not containing FERRIC OXIDE RED

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

relugolix drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix	72974-120
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYL CELLULOSE

relugolix drug variants containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix	72974-120
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix drug variants not containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE 2910

relugolix drug variants containing HYPROMELLOSE 2910

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix	72974-120
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix drug variants not containing HYPROMELLOSE 2910

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

relugolix drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix	72974-120
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

relugolix drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix	72974-120
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

relugolix drug variants containing MANNITOL

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix	72974-120
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix drug variants not containing MANNITOL

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

relugolix drug variants containing SODIUM STARCH GLYCOLATE TYPE A

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix	72974-120
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix drug variants not containing SODIUM STARCH GLYCOLATE TYPE A

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

relugolix drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix	72974-120
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TRIACETIN

relugolix drug variants containing TRIACETIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix, estradiol hemihydrate, and norethindrone acetate	72974-415
>Company	>Ingredient	>NDC

relugolix drug variants not containing TRIACETIN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Sumitomo Pharma America Inc	relugolix	72974-120
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.